1. GPCR/G Protein Neuronal Signaling
  2. 5-HT Receptor
  3. Geissoschizine methyl ether

Geissoschizine methyl ether is an orally active, blood-brain barrier permeable alkaloid, and a partial agonist of the 5-HT1A receptor. It can be isolated from Uncaria hook. Geissoschizine methyl ether potently inhibits the binding of [3H]8-OH-DPAT to the 5-HT1A receptor in a concentration-dependent manner, with an IC50 of 0.904 μM. It ameliorates isolation-induced increased aggression and reduced sociability in mice. Geissoschizine methyl ether promotes oligodendrocyte differentiation and remyelination in the medial prefrontal cortex of adult mice.

For research use only. We do not sell to patients.

Geissoschizine methyl ether

Geissoschizine methyl ether Chemical Structure

CAS No. : 60314-89-8

Size Price Stock Quantity
5 mg In-stock
10 mg In-stock
50 mg   Get quote  
100 mg   Get quote  

* Please select Quantity before adding items.

This product is a controlled substance and not for sale in your territory.

Customer Review

Based on 1 publication(s) in Google Scholar

Top Publications Citing Use of Products

1 Publications Citing Use of MCE Geissoschizine methyl ether

  • Biological Activity

  • Purity & Documentation

  • References

  • Customer Review

Description

Geissoschizine methyl ether is an orally active, blood-brain barrier permeable alkaloid, and a partial agonist of the 5-HT1A receptor. It can be isolated from Uncaria hook. Geissoschizine methyl ether potently inhibits the binding of [3H]8-OH-DPAT to the 5-HT1A receptor in a concentration-dependent manner, with an IC50 of 0.904 μM. It ameliorates isolation-induced increased aggression and reduced sociability in mice. Geissoschizine methyl ether promotes oligodendrocyte differentiation and remyelination in the medial prefrontal cortex of adult mice[1][2][3].

IC50 & Target[1]

5-HT1A Receptor

0.904 μM (IC50)

In Vitro

Geissoschizine methyl ether (0.01-100 μM) potently inhibits the binding of [3H]8-OH-DPAT to 5-HT1A receptors in a concentration-dependent manner, with an IC50 of 0.904 μM and a Ki of 0.517 μM[2].
Geissoschizine methyl ether (0.1-100 μM; 20 min preincubation) acts as a partial agonist of the 5-HT1A receptor in CHO-h5-HT1A cell membranes, and induces approximately 40% of the maximal [35S]GTPγS binding activity triggered by the full agonist 5-HT[2].

MedChemExpress (MCE) has not independently confirmed the accuracy of these methods. They are for reference only.

In Vivo

Geissoschizine methyl ether (150-300 µg/kg; p.o.; once daily; for 14 consecutive days) significantly ameliorates isolation-induced enhanced aggression and reduced sociability in male ddY mice, and its effects are mediated by the 5-HT1A receptor[2].
Geissoschizine methyl ether (0.3 mg/kg; p.o.; once daily; for 14 consecutive days) increases the generation of mature oligodendrocytes in the medial prefrontal cortex of cuprizone-induced demyelinated adult male C57BL/6J mice, and restores MBP immunoreactivity to approximately 85% of the control level[3].
Geissoschizine methyl ether (0.3 mg/kg; p.o.; once daily; for 14 consecutive days) exerts no effect on myelination or proliferating cell populations in the medial prefrontal cortex of healthy adult male C57BL/6J mice[3].

MedChemExpress (MCE) has not independently confirmed the accuracy of these methods. They are for reference only.

Animal Model: ddY (male, 4 weeks old at acquisition, habituated 1 week, isolation-housed 4 weeks to induce behavioral changes)[2]
Dosage: 75 µg/kg (single dose); 150 µg/kg (single dose; 14-day repeated dose); 300 µg/kg (single dose; 14-day repeated dose; 15-day coadministration)
Administration: p.o.; single dose; once daily for 14 days; once daily for 15 days
Result: Significantly ameliorated isolation-induced decreased social behavior at 300 µg/kg single dose (P<0.01), with no effect on aggressive behavior at any single dose tested.
Significantly decreased isolation-induced increased aggressive behavior (P<0.01) and increased isolation-induced decreased social behavior (P<0.01) at 150 µg/kg and 300 µg/kg with 14-day repeated administration.
Counteracted the ameliorative effects of 14-day repeated GM administration on aggressive and social behaviors when 0.1 mg/kg WAY-100635 was given i.p. 30 minutes after final GM dose (P<0.01).
Counteracted the ameliorative effects of 300 µg/kg GM on aggressive and social behaviors when coadministered with 0.1 mg/kg WAY-100635 for 14 days (P<0.05).
Sustained ameliorative effects on aggressive (P<0.05) and social (P<0.01) behaviors on day 15 without GM administration at 300 µg/kg 14-day repeated dose.
Caused no significant changes in motor activity in any treated groups compared to controls.
Animal Model: C57BL/6J (adult male, aged 57-113 days, demyelination induced by 0.2% cuprizone-containing chow for 4 weeks)[3]
Dosage: 0.3 mg/kg
Administration: p.o.; once daily; 14 days
Result: Increased the number of BrdU-labeled GSTpi+ mature oligodendrocytes to 21.1/mm2.
Restored MBP immunoreactivity to 85.19% of control levels.
Restored the ratio of MBP to neurofilament (NF) intensity to 0.28.
Showed no significant effect on body weight, the number of BrdU-labeled NG2+ oligodendrocyte progenitor cells, BrdU-labeled Iba1+ microglial cells, or total GSTpi+ mature oligodendrocytes.
Molecular Weight

366.45

Formula

C22H26N2O3

CAS No.
Appearance

Solid

Color

White to off-white

SMILES

COC(/C([C@H]1C[C@@]2([H])C3=C(CCN2C/C1=C/C)C4=CC=CC=C4N3)=C\OC)=O

Structure Classification
Initial Source
Shipping

Room temperature in continental US; may vary elsewhere.

Storage

4°C, protect from light

*In solvent : -80°C, 6 months; -20°C, 1 month (protect from light)

Solvent & Solubility
In Vitro: 

DMSO : 100 mg/mL (272.89 mM; Need ultrasonic; Hygroscopic DMSO has a significant impact on the solubility of product, please use newly opened DMSO)

Preparing
Stock Solutions
Concentration Solvent Mass 1 mg 5 mg 10 mg
1 mM 2.7289 mL 13.6444 mL 27.2889 mL
5 mM 0.5458 mL 2.7289 mL 5.4578 mL
View the Complete Stock Solution Preparation Table

* Please refer to the solubility information to select the appropriate solvent. Once prepared, please aliquot and store the solution to prevent product inactivation from repeated freeze-thaw cycles.
Storage method and period of stock solution: -80°C, 6 months; -20°C, 1 month (protect from light). When stored at -80°C, please use it within 6 months. When stored at -20°C, please use it within 1 month.

  • Molarity Calculator

  • Dilution Calculator

Mass (g) = Concentration (mol/L) × Volume (L) × Molecular Weight (g/mol)

Mass
=
Concentration
×
Volume
×
Molecular Weight *

Concentration (start) × Volume (start) = Concentration (final) × Volume (final)

This equation is commonly abbreviated as: C1V1 = C2V2

Concentration (start)

C1

×
Volume (start)

V1

=
Concentration (final)

C2

×
Volume (final)

V2

In Vivo Dissolution Calculator
Please enter the basic information of animal experiments:

Dosage

mg/kg

Animal weight
(per animal)

g

Dosing volume
(per animal)

μL

Number of animals

Recommended: Prepare an additional quantity of animals to account for potential losses during experiments.
Calculation results:
Working solution concentration: mg/mL
Purity & Documentation

Purity: 99.97%

References

Complete Stock Solution Preparation Table

* Please refer to the solubility information to select the appropriate solvent. Once prepared, please aliquot and store the solution to prevent product inactivation from repeated freeze-thaw cycles.
Storage method and period of stock solution: -80°C, 6 months; -20°C, 1 month (protect from light). When stored at -80°C, please use it within 6 months. When stored at -20°C, please use it within 1 month.

Optional Solvent Concentration Solvent Mass 1 mg 5 mg 10 mg 25 mg
DMSO 1 mM 2.7289 mL 13.6444 mL 27.2889 mL 68.2221 mL
5 mM 0.5458 mL 2.7289 mL 5.4578 mL 13.6444 mL
10 mM 0.2729 mL 1.3644 mL 2.7289 mL 6.8222 mL
15 mM 0.1819 mL 0.9096 mL 1.8193 mL 4.5481 mL
20 mM 0.1364 mL 0.6822 mL 1.3644 mL 3.4111 mL
25 mM 0.1092 mL 0.5458 mL 1.0916 mL 2.7289 mL
30 mM 0.0910 mL 0.4548 mL 0.9096 mL 2.2741 mL
40 mM 0.0682 mL 0.3411 mL 0.6822 mL 1.7056 mL
50 mM 0.0546 mL 0.2729 mL 0.5458 mL 1.3644 mL
60 mM 0.0455 mL 0.2274 mL 0.4548 mL 1.1370 mL
80 mM 0.0341 mL 0.1706 mL 0.3411 mL 0.8528 mL
100 mM 0.0273 mL 0.1364 mL 0.2729 mL 0.6822 mL
  • No file chosen (Maximum size is: 1024 Kb)
  • If you have published this work, please enter the PubMed ID.
  • Your name will appear on the site.
Help & FAQs
  • Do most proteins show cross-species activity?

    Species cross-reactivity must be investigated individually for each product. Many human cytokines will produce a nice response in mouse cell lines, and many mouse proteins will show activity on human cells. Other proteins may have a lower specific activity when used in the opposite species.

Your Recently Viewed Products:

Inquiry Online

Your information is safe with us. * Required Fields.

Product Name

 

Requested Quantity *

Applicant Name *

 

Salutation

Email Address *

 

Phone Number *

Department

 

Organization Name *

City

State

Country or Region *

     

Remarks

Bulk Inquiry

Inquiry Information

Product Name:
Geissoschizine methyl ether
Cat. No.:
HY-N2411
Quantity:
MCE Japan Authorized Agent: